Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metformin on Inflammaging and Senescence Biomarkers in Prediabetic Adults
2026-527080-15-00Phase 4Authorised
- Sponsor
- Universidad Autónoma de Madrid
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in prediabetes and insulin resistance (IR) (3 arms), sponsored by Universidad Autónoma de Madrid. Planned start Aug 2026; status: authorised.
02
Drugs
metformin
03
Conditions
prediabetesinsulin resistance (IR)
Beyond the preview
Go deeper on 2026-527080-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-527080-15-00.